시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
염증 후 과다 색소 침착 치료 시장 보고서(2025년)
Post-Inflammatory Hyperpigmentation Treatment Global Market Report 2025
상품코드 : 1855960
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

염증 후 과다 색소 침착 치료 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 13억 1,000만 달러로 평가되었고, 2025년에는 14억 7,000만 달러에 달하고, CAGR 12.1%로 성장할 전망입니다. 역사적인 기간의 성장은 피부의 건강과 미용에 대한 의식 증가, 여드름과 습진과 관련된 염증 후 색소 침착의 발생률의 상승, 코스메 슈티컬즈와 고급 국소 크림의 채택 증가, 스킨 케어 클리닉과 피부과 센터의 존재감 증가, 퍼스널케어나 미용 치료에의 지출 증가입니다.

염증 후 과다 색소 침착 치료 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 11.8%로 23억 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 정확한 치료를 위한 피부 진단 도구의 보급, 줄기 세포 및 재생 피부 과학에 대한 연구 투자 증가, 가정용 스킨 케어 장비 및 DIY 솔루션의 인기 증가, 개인화 피부 과학 및 맞춤형 치료 계획의 중요성 증가, 원격 피부 과학 및 가상 진단에 대한 의존성 증가 등이 견인될 것으로 예측됩니다. 예측 기간 동안 예상되는 주요 동향은 피부 진단을 위한 인공지능의 발전, 염료를 표적으로 하는 나노기술 치료의 개발, 줄기세포 및 재생 피부과학 접근법의 응용, 피부 건강 모니터링을 위한 웨어러블 디바이스의 채택, 개인화 및 정밀 피부과학 치료의 시작 등을 포함합니다.

비침습적 피부과 치료에 대한 선호도 증가는 염증 후 과다 색소 침착 치료 시장의 확대를 촉진할 것으로 예측됩니다. 비침습적 피부과 치료는 외과 수술 없이 피부 상태를 개선 또는 관리하는 의료 및 미용 치료로, 일반적으로 외용제, 에너지 기반 장비 또는 절개 및 조직 절제를 피하는 최소한의 파괴적인 방법을 사용합니다. 수요 증가는 주로 최소한의 다운타임으로 눈에 보이는 개선을 가져오는 효과적인 해결책을 요구하는 개인에 의한 것으로, 수술 옵션에 비해 위험과 불편함을 줄이면서 활동적인 라이프 스타일에 맞출 수 있습니다. 염증 후 과다 색소 침착 치료는 피부의 얼룩이나 변색에 대한 대상을 좁힌 비외과적 솔루션을 제공하고, 비침습적 피부과 옵션의 인기와 보급을 높이는 것으로, 이 동향에 합치하고 있습니다. 예를 들어, 2024년 6월 미국 성형외과학회는 2023년 저침습 수술이 7% 증가했고 수술을 2% 웃돌았다고 보고했습니다. 신경조절제 주사와 히알루론산 충전제는 각각 900만건과 500만건의 치료를 돌파했습니다. 따라서 비침습적인 피부과 치료에 대한 수요 증가는 염증 후 과다 색소 침착 치료 시장의 성장을 뒷받침하고 있습니다.

염증 후 과다 색소 침착 치료 시장의 주요 기업은 복잡한 염료 장애를 관리하기 위한 임상적으로 입증된 옵션을 확장하기 위해 피코초 피부과 레이저와 같은 고급 솔루션의 개발에 주력하고 있습니다. 피코초 피부과 레이저는 복수의 파장에서 매우 짧은 레이저 펄스를 조사했으며, 주위 조직에의 열 손상을 최소한으로 억제하면서, 불필요한 피부 색소나 문신을 분해·분산시킵니다. 예를 들어, 2023년 3월 미국에 본사를 둔 세계적인 의료 및 미용 장비 회사인 Candela Corporation은 PicoWay 레이저 시스템을 출시했습니다. 이 장치는 미국 식품의약국과 캐나다 보건성으로부터 간반, 쿠로코, 카페오레반, 오타 모반 등의 과제인 색소성 질환의 치료에 대한 규제 인가를 받았습니다. 이번 승인 확대에 의해 열에 의한 부작용을 경감하면서, 피부 아래의 색소를 타겟으로 하는 초단피코초 펄스를 조사하는 것이 가능하게 되어, 다양한 피부 유형이나 색소성 질환에 대해서, 보다 안전하고 범용성이 높은 선택지가 됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Post-inflammatory hyperpigmentation treatment refers to professional dermatological and aesthetic interventions designed to reduce or eliminate skin discoloration resulting from inflammation or injury. These treatments include chemical peels, laser therapy, microdermabrasion, topical formulations, and advanced dermatology-guided procedures that restore skin tone, improve appearance, and promote overall skin health.

The primary product categories of post-inflammatory hyperpigmentation treatment include topical creams, oral medications, laser therapy, chemical peels, microdermabrasion, and others. Topical creams are dermatologically developed formulations applied to the skin to lighten dark spots, even out skin tone, and reduce pigmentation caused by inflammation or injury. These products are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels, serving end users such as hospitals, dermatology clinics, homecare settings, and related facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The post-inflammatory hyperpigmentation treatment market research report is one of a series of new reports from The Business Research Company that provides post-inflammatory hyperpigmentation treatment market statistics, including post-inflammatory hyperpigmentation treatment industry global market size, regional shares, competitors with a post-inflammatory hyperpigmentation treatment market share, detailed post-inflammatory hyperpigmentation treatment market segments, market trends and opportunities, and any further data you may need to thrive in the post-inflammatory hyperpigmentation treatment industry. This post-inflammatory hyperpigmentation treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The post-inflammatory hyperpigmentation treatment market size has grown rapidly in recent years. It will grow from $1.31 billion in 2024 to $1.47 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth during the historic period was supported by rising awareness of skin health and aesthetics, higher incidence of post-inflammatory hyperpigmentation linked to acne and eczema, increasing adoption of cosmeceuticals and advanced topical creams, greater presence of skincare clinics and dermatology centers, and higher spending on personal care and aesthetic treatments.

The post-inflammatory hyperpigmentation treatment market size is expected to see rapid growth in the next few years. It will grow to $2.30 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth during the forecast period is expected to be driven by wider use of skin diagnostic tools for precise treatment, increasing research investment in stem-cell and regenerative dermatology, rising popularity of at-home skincare devices and do-it-yourself solutions, growing emphasis on personalized dermatology and customized treatment plans, and greater reliance on teledermatology and virtual consultations. Key trends anticipated in the forecast period include advances in artificial intelligence for skin diagnostics, development of pigment-targeting nanotechnology therapies, application of stem cell and regenerative dermatology approaches, adoption of wearable devices for skin health monitoring, and the rise of personalized and precision dermatology treatments.

The growing preference for non-invasive dermatology treatments is expected to fuel the expansion of the post-inflammatory hyperpigmentation treatment market. Non-invasive dermatology treatments involve medical or aesthetic procedures that improve or manage skin conditions without surgery, typically using topical products, energy-based devices, or minimally disruptive methods that avoid cuts or tissue removal. The rising demand is mainly driven by individuals seeking effective solutions that provide visible improvements with minimal downtime, aligning with active lifestyles while reducing risks and discomfort compared to surgical options. Post-inflammatory hyperpigmentation treatment fits this trend by offering targeted, non-surgical solutions for uneven skin tone and discoloration, increasing the popularity and adoption of non-invasive dermatology options. For example, in June 2024, the American Society of Plastic Surgeons reported that minimally invasive procedures grew by 7 percent in 2023, outpacing surgical procedures by 2 percent. Neuromodulator injections and hyaluronic acid fillers each surpassed 9 million and 5 million treatments, respectively. Therefore, the rising demand for non-invasive dermatology treatments is propelling the growth of the post-inflammatory hyperpigmentation treatment market.

Key players in the post-inflammatory hyperpigmentation treatment market are focusing on developing advanced solutions such as picosecond dermatology lasers to expand clinically proven options for managing complex pigmentary disorders. A picosecond dermatology laser emits extremely short laser pulses at multiple wavelengths to break down and disperse unwanted skin pigments or tattoos with minimal heat damage to surrounding tissues. For instance, in March 2023, Candela Corporation, a US-based global medical aesthetic device company, launched the PicoWay laser system. This device received regulatory clearance from the US Food and Drug Administration and Health Canada to treat challenging pigmentary conditions, including melasma, lentigines, cafe-au-lait macules, and Nevus of Ota. The expanded approval allows the device to deliver ultra-short picosecond pulses that target pigment beneath the skin while reducing heat-related side effects, making it a safer and more versatile option for a wide variety of skin types and pigmentary disorders.

In April 2024, Cynosure LLC, a US-based provider of aesthetic and medical treatment systems, merged with Lutronic for an undisclosed amount. The merger aims to create a comprehensive medical aesthetic systems company by combining Cynosure's and Lutronic's innovative energy-based technologies. This collaboration will expand their product portfolios, boost research and development capabilities, and enhance their commercial reach to better serve customers and patients globally. Lutronic is a South Korean company specializing in aesthetic and medical laser systems.

Major players in the post-inflammatory hyperpigmentation treatment market are Johnson & Johnson, Procter & Gamble Co., Unilever plc, AbbVie Inc., Bayer AG, L'Oreal Group, Estee Lauder Companies Inc., Beiersdorf AG, Shiseido Company Limited, Coty Inc., Galderma S.A., Pierre Fabre Group, Amorepacific Corporation, Obagi Cosmeceuticals LLC (Waldencast Acquisition Corp), Mesoestetic, Murad LLC, Soma Medical Spa, The Naderi Center, Orange Coast Aesthetics, Cutis Medical Laser Clinics.

North America was the largest region in the post-inflammatory hyperpigmentation treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in post-inflammatory hyperpigmentation treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the post-inflammatory hyperpigmentation treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The post-inflammatory hyperpigmentation treatment market consists of revenues earned by entities by providing services such as dermatology consultations, teledermatology services, at-home skincare consultations, virtual skincare consultations, skincare routine personalization, and dermatology telehealth services. The market value includes the value of related goods sold by the service provider or included within the service offering. The post-inflammatory hyperpigmentation treatment market also includes sales of products such as cosmetic serums, brightening face masks, skin-lightening lotions, niacinamide-based products, alpha arbutin formulations, licorice extract creams, tranexamic acid serums, retinol-based treatments, vitamin E oils, and peptide-enriched creams. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Post-Inflammatory Hyperpigmentation Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on post-inflammatory hyperpigmentation treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for post-inflammatory hyperpigmentation treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The post-inflammatory hyperpigmentation treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Post-Inflammatory Hyperpigmentation Treatment Market Characteristics

3. Post-Inflammatory Hyperpigmentation Treatment Market Trends And Strategies

4. Post-Inflammatory Hyperpigmentation Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Post-Inflammatory Hyperpigmentation Treatment Growth Analysis And Strategic Analysis Framework

6. Post-Inflammatory Hyperpigmentation Treatment Market Segmentation

7. Post-Inflammatory Hyperpigmentation Treatment Market Regional And Country Analysis

8. Asia-Pacific Post-Inflammatory Hyperpigmentation Treatment Market

9. China Post-Inflammatory Hyperpigmentation Treatment Market

10. India Post-Inflammatory Hyperpigmentation Treatment Market

11. Japan Post-Inflammatory Hyperpigmentation Treatment Market

12. Australia Post-Inflammatory Hyperpigmentation Treatment Market

13. Indonesia Post-Inflammatory Hyperpigmentation Treatment Market

14. South Korea Post-Inflammatory Hyperpigmentation Treatment Market

15. Western Europe Post-Inflammatory Hyperpigmentation Treatment Market

16. UK Post-Inflammatory Hyperpigmentation Treatment Market

17. Germany Post-Inflammatory Hyperpigmentation Treatment Market

18. France Post-Inflammatory Hyperpigmentation Treatment Market

19. Italy Post-Inflammatory Hyperpigmentation Treatment Market

20. Spain Post-Inflammatory Hyperpigmentation Treatment Market

21. Eastern Europe Post-Inflammatory Hyperpigmentation Treatment Market

22. Russia Post-Inflammatory Hyperpigmentation Treatment Market

23. North America Post-Inflammatory Hyperpigmentation Treatment Market

24. USA Post-Inflammatory Hyperpigmentation Treatment Market

25. Canada Post-Inflammatory Hyperpigmentation Treatment Market

26. South America Post-Inflammatory Hyperpigmentation Treatment Market

27. Brazil Post-Inflammatory Hyperpigmentation Treatment Market

28. Middle East Post-Inflammatory Hyperpigmentation Treatment Market

29. Africa Post-Inflammatory Hyperpigmentation Treatment Market

30. Post-Inflammatory Hyperpigmentation Treatment Market Competitive Landscape And Company Profiles

31. Post-Inflammatory Hyperpigmentation Treatment Market Other Major And Innovative Companies

32. Global Post-Inflammatory Hyperpigmentation Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Post-Inflammatory Hyperpigmentation Treatment Market

34. Recent Developments In The Post-Inflammatory Hyperpigmentation Treatment Market

35. Post-Inflammatory Hyperpigmentation Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기